DekaBank Deutsche Girozentrale’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-21,500	Closed	-$113K	–	1264
2019 Q3	$113K	Sell	21,500 -21,500	-50%	-$113K	﹤0.01%	904
2019 Q2	$250K	Buy	43,000 +16,500	+62%	+$95.9K	﹤0.01%	996
2019 Q1	$208K	Buy	26,500 +5,000	+23%	+$39.2K	﹤0.01%	1036
2018 Q4	$84K	Sell	21,500 -5,000	-19%	-$19.5K	﹤0.01%	1087
2018 Q3	$208K	Sell	26,500 -500	-2%	-$3.93K	﹤0.01%	1058
2018 Q2	$219K	Buy	27,000 +18,000	+200%	+$146K	﹤0.01%	1034
2018 Q1	$66K	Hold	9,000	–	–	﹤0.01%	1074
2017 Q4	$52K	Hold	9,000	–	–	﹤0.01%	1016
2017 Q3	$52K	Hold	9,000	–	–	﹤0.01%	1024
2017 Q2	$63K	Hold	9,000	–	–	﹤0.01%	995
2017 Q1	$86K	Sell	9,000 -1,000	-10%	-$9.56K	﹤0.01%	916
2016 Q4	$90K	Buy	+10,000	New	+$90K	﹤0.01%	928
2016 Q2	–	Sell	-34,500	Closed	-$147K	–	1077
2016 Q1	$147K	Sell	34,500 -1,000	-3%	-$4.26K	﹤0.01%	898
2015 Q4	$221K	Buy	35,500 +500	+1%	+$3.11K	﹤0.01%	846
2015 Q3	$200K	Buy	35,000 +1,000	+3%	+$5.71K	﹤0.01%	870
2015 Q2	$254K	Buy	34,000 +1,500	+5%	+$11.2K	﹤0.01%	832
2015 Q1	$194K	Sell	32,500 -5,000	-13%	-$29.8K	﹤0.01%	914
2014 Q4	$271K	Sell	37,500 -3,000	-7%	-$21.7K	﹤0.01%	811
2014 Q3	$210K	Buy	40,500 +500	+1%	+$2.59K	﹤0.01%	803
2014 Q2	$172K	Buy	40,000 +4,500	+13%	+$19.4K	﹤0.01%	770
2014 Q1	$145K	Buy	35,500 +1,000	+3%	+$4.09K	﹤0.01%	762
2013 Q4	$189K	Buy	34,500 +1,000	+3%	+$5.48K	﹤0.01%	672
2013 Q3	$169K	Buy	+33,500	New	+$169K	﹤0.01%	684